Ipsen becomes the latest pharma to expand in Ireland, with a $50M investment in its facility in Dublin suburbs

On Monday Ipsen unveiled the €52 million ($49.9 million) expansion it made into its active pharmaceutical ingredient manufacturing facility in Blanchardstown, a small suburb of Dublin. The investment is aimed at boosting medicine and ingredient production in cancer and rare disease space.